摘要
标题化合物是一个重要的精细化工中间体,可用于制备嘧啶类、吡唑类等产品。本文利用红外光谱(IR)、质谱(MS)、核磁共振氢谱(^(1)H NMR)、核磁共振碳谱(^(13)C NMR)和X-射线单晶衍射对此化合物进行了表征,并在B3LYP/6-311G(d,p)模式下使用密度泛函理论(DFT)计算了此化合物的最稳定晶体结构以及最高占有分子轨道(HOMO)和最低占有分子轨道(LUMO)能量。结果表明,通过DFT优化的分子结构与X-射线单晶衍射确定的晶体结构基本一致,该化合物属于单斜方P2(1)/n空间群,晶胞参数为:a=1.5639(10)nm,b=0.7786(4)nm,c=1.8382(10)nm,Z=4,ρc=1.345 g·cm^(-3),R=0.0477,R_(w)=0.1387。
The title compound is an important fine chemical intermediate,which can be used to prepare kinds of pyrimidines and pyrazoles products.This compound was characterized by IR,MS,^(1)H NMR,^(13)C NMR and X-ray single crystal diffraction,and the most stable crystal structure,HOMO and LUMO energy were calculated by using density functional theory(DFT)in B3LYP/6-311G(d,p)mode.The results show that the molecular structure optimized by DFT is consistent with the crystal structure determined by X-ray single crystal diffraction.The compound belongs to the monoclinic P2(1)/n space group,its crystallographic parameters are as follows:a=1.5639(10)nm,b=0.7786(4)nm,c=1.8382(10)nm,Z=4,ρc=1.345 g·cm^(-3),R=0.0477,R_(w)=0.1387.
作者
任倩
刘叶
高婷
周志旭
赵春深
柴慧芳
REN Qian;LIU Ye;GAO Ting;ZHOU Zhixu;ZHAO Chunshen;CHAI Huifang(School of Pharmaceutical Sciences, Guizhou University, Guiyang 550025, China;Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang 550025, China;College of Pharmacy, Guizhou University of Chinese Medicine, Guiyang 550025, China)
出处
《人工晶体学报》
CAS
北大核心
2021年第2期338-344,共7页
Journal of Synthetic Crystals
基金
贵州省科技计划(黔科合SY字[2017]1049,黔科合基础[2020]1Y393,黔科合平台人才[2018]5781)
贵州中医药大学2018年度学术新苗培养及创新探索专项项目培育项目计划(黔科合平台人才[2018]5766号-14)。